<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatrics</journal-id><journal-id journal-id-type="iso-abbrev">Pediatrics</journal-id><journal-id journal-id-type="pmc-domain-id">2530</journal-id><journal-id journal-id-type="pmc-domain">hhspa</journal-id><journal-title-group><journal-title>Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">0031-4005</issn><issn pub-type="epub">1098-4275</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>HHS Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10142390</article-id><article-id pub-id-type="pmcid-ver">PMC10142390.1</article-id><article-id pub-id-type="pmcaid">10142390</article-id><article-id pub-id-type="pmcaiid">10142390</article-id><article-id pub-id-type="manuscript-id">NIHMS1894244</article-id><article-id pub-id-type="pmid">36691760</article-id><article-id pub-id-type="doi">10.1542/peds.2022-058755</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1894244</article-id><article-id pub-id-type="manuscript-id-alternative">HHSPA1894244</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Buprenorphine Dispensing Among Youth Aged &#8804;19 Years in the United States: 2015&#8211;2020</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Terranella</surname><given-names initials="A">Andrew</given-names></name><degrees>MD, MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guy</surname><given-names initials="GP">Gery P.</given-names><suffix>Jr</suffix></name><degrees>PhD, MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mikosz</surname><given-names initials="C">Christina</given-names></name><degrees>MD, MPH</degrees></contrib><aff id="A1">Division of Overdose Prevention, Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia</aff></contrib-group><author-notes><fn fn-type="con" id="FN1"><p id="P1">Dr Terranella conceptualized and designed the study, performed the data analysis, and drafted the initial manuscript; Drs Guy and Mikosz conceptualized and designed the study; and all authors reviewed and revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.</p></fn><corresp id="CR1">Address correspondence to Andrew Terranella, MD, MPH, Division of Overdose Prevention, CDC, 4770 Buford Hwy NE, Atlanta, GA 30341. <email>aqt1@cdc.gov</email></corresp><fn fn-type="COI-statement" id="FN3"><p id="P29"><bold>CONFLICT OF INTEREST DISCLOSURES:</bold> The authors have indicated they have no conflicts of interest relevant to this article to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>2</month><year>2023</year></pub-date><volume>151</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">434520</issue-id><elocation-id>e2022058755</elocation-id><pub-history><event event-type="nihms-submitted"><date><day>21</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-16 17:25:54.240"><day>16</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1894244.pdf"/><abstract id="ABS1"><sec id="S1"><title>BACKGROUND AND OBJECTIVES:</title><p id="P2">Opioid related overdose among adolescents and young adults in the United States is rising. Medications for opioid use disorder (MOUD), including buprenorphine can reduce the risk of overdose, however they are underutilized. A better understanding of buprenorphine prescribing to youth will help inform interventions to expand access to treatment.</p></sec><sec id="S2"><title>METHODS:</title><p id="P3">We used IQVIA data to examine buprenorphine dispensing trends among youth aged &#8804;19 years from 2015 to 2020. Dispensing was examined by prescriber specialty, age, and sex. Data were weighted to provide national estimates.</p></sec><sec id="S3"><title>RESULTS:</title><p id="P4">The rate of buprenorphine dispensed to youth decreased 25% over the study period, from 0.84 to 0.63 prescriptions per 1000 youth per year. The proportion of youth dispensed buprenorphine also decreased 45%, from 7.6 to 4.2 persons per 100 000 per year. Over the same time, the proportion of adults aged &#8805;20 years dispensed buprenorphine increased 47%, from 378 to 593 persons per 100 000. Differences in dispensing by sex and temporal trends were also noted. Pediatricians accounted for less-than 2% of all prescriptions dispensed.</p></sec><sec id="S4"><title>CONCLUSIONS:</title><p id="P5">Buprenorphine dispensing to youth is low and declining in recent years. Given rates of opioid use disorder among youth, these findings suggest that many youth who could benefit from MOUD are not receiving it. Pediatricians could play a role in expanding access to MOUD for this high-risk population. Efforts to expand access to MOUD for adolescents could include improving training in opioid use disorder treatment of pediatricians and encouraging all clinicians who care for adolescents and young adults to obtain waivers to prescribe buprenorphine for MOUD.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>